190 related articles for article (PubMed ID: 18456733)
1. Wnt5a is expressed in murine and human atherosclerotic lesions.
Christman MA; Goetz DJ; Dickerson E; McCall KD; Lewis CJ; Benencia F; Silver MJ; Kohn LD; Malgor R
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2864-70. PubMed ID: 18456733
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.
Xu XH; Shah PK; Faure E; Equils O; Thomas L; Fishbein MC; Luthringer D; Xu XP; Rajavashisth TB; Yano J; Kaul S; Arditi M
Circulation; 2001 Dec; 104(25):3103-8. PubMed ID: 11748108
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions.
Malgor R; Bhatt PM; Connolly BA; Jacoby DL; Feldmann KJ; Silver MJ; Nakazawa M; McCall KD; Goetz DJ
Inflamm Res; 2014 Apr; 63(4):277-85. PubMed ID: 24346141
[TBL] [Abstract][Full Text] [Related]
5. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
6. Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis.
Ackers I; Szymanski C; Duckett KJ; Consitt LA; Silver MJ; Malgor R
Cardiovasc Pathol; 2018; 34():1-8. PubMed ID: 29474941
[TBL] [Abstract][Full Text] [Related]
7. siRNA-mediated silencing of Wnt5a regulates inflammatory responses in atherosclerosis through the MAPK/NF-κB pathways.
Yang L; Chu Y; Wang Y; Zhao X; Xu W; Zhang P; Liu X; Dong S; He W; Gao C
Int J Mol Med; 2014 Oct; 34(4):1147-52. PubMed ID: 25050997
[TBL] [Abstract][Full Text] [Related]
8. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
10. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.
Nahon JE; Hoekstra M; Havik SR; Van Santbrink PJ; Dallinga-Thie GM; Kuivenhoven JA; Geerling JJ; Van Eck M
Atherosclerosis; 2018 Jul; 274():120-127. PubMed ID: 29772480
[TBL] [Abstract][Full Text] [Related]
11. Intracellular AIBP (Apolipoprotein A-I Binding Protein) Regulates Oxidized LDL (Low-Density Lipoprotein)-Induced Mitophagy in Macrophages.
Choi SH; Agatisa-Boyle C; Gonen A; Kim A; Kim J; Alekseeva E; Tsimikas S; Miller YI
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e82-e96. PubMed ID: 33356389
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
13. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53.
Sayin VI; Khan OM; Pehlivanoglu LE; Staffas A; Ibrahim MX; Asplund A; Agren P; Nilton A; Bergström G; Bergo MO; Borén J; Lindahl P
Circ Res; 2014 Oct; 115(9):781-9. PubMed ID: 25212213
[TBL] [Abstract][Full Text] [Related]
14. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
[TBL] [Abstract][Full Text] [Related]
15. Wnt6 is expressed in granulomatous lesions of Mycobacterium tuberculosis-infected mice and is involved in macrophage differentiation and proliferation.
Schaale K; Brandenburg J; Kispert A; Leitges M; Ehlers S; Reiling N
J Immunol; 2013 Nov; 191(10):5182-95. PubMed ID: 24123681
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
[TBL] [Abstract][Full Text] [Related]
18. The novel role and underlying mechanism of Wnt5a in regulating cellular cholesterol accumulation.
Qin L; Hu R; Zhu N; Yao HL; Lei XY; Li SX; Liao DF; Zheng XL
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):671-8. PubMed ID: 24827906
[TBL] [Abstract][Full Text] [Related]
19. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
